IM Cannabis (IMCC) Competitors $1.69 +0.19 (+12.67%) As of 04/30/2025 03:41 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IMCC vs. SYBX, NXTC, IMNN, NERV, RLYB, RLMD, ABVC, LSB, ATHA, and BGXXShould you be buying IM Cannabis stock or one of its competitors? The main competitors of IM Cannabis include Synlogic (SYBX), NextCure (NXTC), Imunon (IMNN), Minerva Neurosciences (NERV), Rallybio (RLYB), Relmada Therapeutics (RLMD), ABVC BioPharma (ABVC), Lakeshore Biopharma (LSB), Athira Pharma (ATHA), and Bright Green (BGXX). These companies are all part of the "pharmaceutical products" industry. IM Cannabis vs. Synlogic NextCure Imunon Minerva Neurosciences Rallybio Relmada Therapeutics ABVC BioPharma Lakeshore Biopharma Athira Pharma Bright Green Synlogic (NASDAQ:SYBX) and IM Cannabis (NASDAQ:IMCC) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, community ranking, profitability and dividends. Which has higher valuation & earnings, SYBX or IMCC? IM Cannabis has higher revenue and earnings than Synlogic. IM Cannabis is trading at a lower price-to-earnings ratio than Synlogic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynlogic$8K1,666.68-$57.28M-$2.51-0.45IM Cannabis$54.03M0.07-$7.04M-$2.56-0.66 Does the MarketBeat Community favor SYBX or IMCC? Synlogic received 325 more outperform votes than IM Cannabis when rated by MarketBeat users. Likewise, 69.54% of users gave Synlogic an outperform vote while only 42.86% of users gave IM Cannabis an outperform vote. CompanyUnderperformOutperformSynlogicOutperform Votes33169.54% Underperform Votes14530.46% IM CannabisOutperform Votes642.86% Underperform Votes857.14% Which has more risk and volatility, SYBX or IMCC? Synlogic has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500. Comparatively, IM Cannabis has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Do institutionals and insiders believe in SYBX or IMCC? 63.4% of Synlogic shares are owned by institutional investors. Comparatively, 7.7% of IM Cannabis shares are owned by institutional investors. 3.0% of Synlogic shares are owned by company insiders. Comparatively, 5.9% of IM Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is SYBX or IMCC more profitable? Synlogic has a net margin of 0.00% compared to IM Cannabis' net margin of -25.55%. IM Cannabis' return on equity of -129.86% beat Synlogic's return on equity.Company Net Margins Return on Equity Return on Assets SynlogicN/A -207.84% -114.81% IM Cannabis -25.55%-129.86%-23.63% Does the media prefer SYBX or IMCC? In the previous week, Synlogic and Synlogic both had 2 articles in the media. Synlogic's average media sentiment score of 1.44 beat IM Cannabis' score of 0.44 indicating that Synlogic is being referred to more favorably in the media. Company Overall Sentiment Synlogic Positive IM Cannabis Neutral SummarySynlogic beats IM Cannabis on 8 of the 14 factors compared between the two stocks. Get IM Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for IMCC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IMCC vs. The Competition Export to ExcelMetricIM CannabisMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.77M$1.19B$5.57B$7.83BDividend YieldN/AN/A5.11%4.22%P/E Ratio-0.5010.4522.4218.48Price / Sales0.0710.33394.10103.91Price / CashN/A10.4038.1834.62Price / Book0.371.456.774.25Net Income-$7.04M-$54.34M$3.22B$248.23M7 Day Performance10.10%11.77%3.25%3.29%1 Month Performance-8.15%22.62%0.01%2.42%1 Year Performance-67.25%-38.98%18.00%5.54% IM Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IMCCIM Cannabis0.4174 of 5 stars$1.69+12.7%N/A-67.2%$3.35M$54.03M-0.50340Upcoming EarningsShort Interest ↑SYBXSynlogic2.4441 of 5 stars$1.12-3.8%N/A-36.3%$13.10M$8,000.00-0.2780Short Interest ↓Positive NewsGap DownNXTCNextCure4.647 of 5 stars$0.46+1.0%$3.50+653.0%-61.5%$13.04MN/A-0.2290Short Interest ↓Positive NewsGap UpIMNNImunon2.6946 of 5 stars$0.86-2.0%$21.50+2,400.0%-35.9%$12.57M$500,000.00-0.4630Short Interest ↓Positive NewsGap DownNERVMinerva Neurosciences3.638 of 5 stars$1.76flat$5.00+184.1%-29.2%$12.31MN/A-4.009RLYBRallybio2.3776 of 5 stars$0.29-4.0%$10.00+3,332.9%-83.3%$12.12M$636,000.00-0.1840Gap DownRLMDRelmada Therapeutics4.2714 of 5 stars$0.36-44.6%$4.25+1,090.1%-91.1%$11.85MN/A-0.1210Upcoming EarningsGap DownHigh Trading VolumeABVCABVC BioPharma1.0933 of 5 stars$1.00+2.4%N/A-15.2%$11.71M$509,589.00-1.1630Earnings ReportPositive NewsLSBLakeshore Biopharma1.3131 of 5 stars$1.24+1.6%N/AN/A$11.54M$672.27M0.00773Short Interest ↓ATHAAthira Pharma3.2147 of 5 stars$0.29+3.4%$13.83+4,605.2%-85.7%$11.48MN/A-0.1040Positive NewsGap UpBGXXBright GreenN/AN/AN/AN/A$11.47MN/A-1.002Gap Down Related Companies and Tools Related Companies SYBX Competitors NXTC Competitors IMNN Competitors NERV Competitors RLYB Competitors RLMD Competitors ABVC Competitors LSB Competitors ATHA Competitors BGXX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IMCC) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IM Cannabis Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share IM Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IMCC Stock Free IMCC Stock Alerts